Equitable Trust CO Biogen Inc. Transaction History

Equitable Trust CO

  • $1.72 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$216.71 - $338.96 $413,265 - $646,396
-1,907 Closed
0 $0
Q4 2018

Feb 22, 2019
SELL
$278.5 - $352.75 $102,209 - $129,459
-367 Reduced 16.14%
1,907 $574,000
Q3 2018

Nov 15, 2018
SELL
$293.51 - $383.83 $191,662 - $250,640
-653 Reduced 22.31%
2,274 $804,000
Q2 2018

Aug 14, 2018
BUY
$257.52 - $306.91 $753,761 - $898,325
2,927 New
2,927 $849,000

Others Institutions Holding BIIB

# of Institutions
995
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email